Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version

For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.


Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/3705/syndication
  • Syndication ID: 1492
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Saturday, September 14, 2013 at 09:01 AM
  • Date Syndication Updated: Saturday, August 29, 2026 at 01:21 AM

Tags

General: prevention health policy treatment childhood acute cessation leukemia version professional lymphoblastic secondhand smoke childhood acute lymphoblastic leukemia T-cell childhood acute lymphoblastic leukemia Philadelphia chromosome-positive childhood acute lymphoblastic leukemia Smoking Use and Tobacco Facts Quitting Resources Guidance, Regulations and Compliance Prevent Smoking and Tobacco Use

Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.
Connect With Us

Share on facebook Visit the HHS Twitter account Share on youtube

Share on flickr Share on pinterest Visit HHS GooglePlus account

U.S. Department of Health & Human Services - 200 Independence Avenue, S.W. - Washington, D.C. 20201